North America Biobanks Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product and Service (Equipment, Consumables, Service, and Software), Sample (Blood Products, Human Tissues, Cell Lines, and Others), and Application (Regenerative Medicine, Life Science Research, and Clinical Research)
The biobanks market in North America is expected to grow from US$ 875.19 million in 2021 to US$ 1,386.56 million by 2028; it is estimated to grow at a CAGR of 6.8% from 2021 to 2028.
Regenerative therapies help induce the regeneration of cells, tissues, and organs and restore their functions. Each year, the increasing number of regenerative medicine applications for human clinical trials is submitted to the Food and Drug Administration (FDA). As per the Alliance for Regenerative Medicine, in the Q3 of 2019, 1,052 clinical trials utilizing regenerative medicine were underway globally. Also, 218 cellular therapy trials were underway (41 Phase I, 147 Phase II, 30 Phase III) in 2019. Rapid advancements in regenerative medicines to provide effective solutions for chronic conditions drive market growth. Cell therapy is one of the fastest-growing segments of the regenerative medicine domain. Novartis’s Kymriah was the first cell therapy solution to treat B-cell acute leukemia. Moreover, RepliCel, a regenerative medicine provider, has a wide range of regenerative medicine products in the pipeline, with three products—RCH-01, RCS-01, and RCT-01—in the development phase. Further, Sernova is engaged in developing regenerative medicine technologies and has a huge pipeline of products for various conditions, such as diabetes, Hemophilia A, and hyperthyroidism. Biobank is a major asset in the field of regenerative medicine as it provides materials for research, development, and therapy. Furthermore, associating each biospecimen (in part or in whole) with relevant patient demographics and medical data can be a source of big data that leads to improved patient outcomes and new therapeutic approaches developments. As the foundation for a successful regenerative medicine and tissue engineering program, investing in biobanking can yield considerable cost recoveries. Thus, the rising adoption of regenerative medicines propels the growth of the biobanks market.The COVID-19 pandemic was an once-in-a-lifetime occurrence that had far-reaching health-care, economic, and societal consequences around the world. The health-care system in North America faced an immediate issue in estimating the demographics of COVID-19's impact. In the absence of precise data, a lockdown was enforced early, putting the health-care system under even more strain to care for non-COVID-19 patients who needed immediate attention. The lockdown had an immediate impact on logistics and supply lines, which had an impact on health-care delivery in the region. In the early stages of COVID-19, biobanking activities in Canada were considered a non-essential health care service, but as necessary research operations began, COVID-19–related studies were permitted and launched. Biobanking became a necessary service as a result of this development, allowing for faster COVID-19 research and the continuation of critical research operations. During the epidemic, navigating the scarce and frequently competing health-care supply chains was critical for continuous operational demands. biobanks have had to purchase extra personal protective equipment (PPE) to safeguard their personnel from COVID-19, and even employees have had to be regularly checked for suspected COVID-19 symptoms. Biobanks had to communicate and search globally for the materials they required to quickly collect and store specimens. Biobanks are critical in collecting and preserving biosamples such as plasma, serum, DNA and RNA, clinical data, and genomic data due to the large number of clinical trials related to COVID-19.With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the North America biobanks market. The North America biobanks market is expected to grow at a good CAGR during the forecast period.
North America Biobanks market Revenue and Forecast to 2028 (US$ Million)
North America Biobanks Market Segmentation
North America Biobanks Market – By Product and Service
- Equipment
- Storage Equipment
- Sample Analysis Equipment
- Sample Processing Equipment
- Sample Transport Equipment
- Consumables
- Storage Consumables
- Analysis Consumables
- Processing Consumables
- Collection Consumables
- Service
- Storage Services
- Processing Services
- Transport Services
- Supply Services
- Software
North America Biobanks Market – By Sample
- Blood Products
- Human Tissues
- Cell Lines
- Others
North America Biobanks Market – By Application
- Regenerative Medicine
- Life Science Research
- Clinical Research
North America Biobanks Market – By Country
- US
- Canada
- Mexico
North America Biobanks Market – Companies Mentioned
- THERMO FISHER SCIENTIFIC INC.
- Tecan Trading AG
- QIAGEN
- Hamilton Company
- Avantor, Inc.
- MICRONICS JAPAN CO., LTD.
- BD
- Taylor-Wharton
- Brooks Automation, Inc.
- Promega Corporation
- SciSafe Inc.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Biobanks Market – By Product and Service
1.3.2 Asia Pacific Biobanks Market – By Sample
1.3.3 Asia Pacific Biobanks Market – By Application
1.3.4 Asia Pacific Biobanks Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Biobanks Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Experts Opinion
5. Asia Pacific Biobanks Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Surging Funding and Genomic Research Activities for Studying Diseases
5.1.2 Scaling Adoption of Regenerative Medicines
5.2 Market Restraints
5.2.1 Extensive Cost of Automation
5.3 Market Opportunities
5.3.1 Raising Adoption of Cell Therapy in Developing Regions
5.4 Future Trends
5.4.1 Virtual Biobanks
5.5 Impact Analysis
6. Asia Pacific Biobanks Market Analysis
6.1 Asia Pacific Biobanks Market Revenue Forecast and Analysis
6.2 Asia Pacific: Biobanks Market - Revenue and Forecast to 2028 (USD Million)
7. Asia Pacific Biobanks Market – by Product and Service
7.1 Overview
7.2 Asia Pacific Biobanks Market, By Product and Service, 2021 & 2028 (%)
7.3 Equipment
7.3.1 Overview
7.3.2 Equipment: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)
7.3.2.1 Storage Equipment
7.3.2.1.1 Overview
7.3.2.1.2 Storage Equipment: Biobanks Market Revenue and Forecast to 2028 (US$ Million)
7.3.2.2 Sample Analysis Equipment
7.3.2.2.1 Overview
7.3.2.2.2 Sample Analysis Equipment: Biobanks Market Revenue and Forecast to 2028 (US$ Million)
7.3.2.3 Sample Processing Equipment
7.3.2.3.1 Overview
7.3.2.3.2 Sample Processing Equipment: Biobanks Market Revenue and Forecast to 2028 (US$ Million)
7.3.2.4 Sample Transport Equipment
7.3.2.4.1 Overview
7.3.2.4.2 Sample Transport Equipment: Biobanks Market Revenue and Forecast to 2028 (US$ Million)
7.4 Consumables
7.4.1 Overview
7.4.2 Consumables: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)
7.4.2.1 Storage Consumables
7.4.2.1.1 Overview
7.4.2.1.2 Storage Consumables: Biobanks Market Revenue and Forecast to 2028 (US$ Million)
7.4.2.2 Analysis Consumables
7.4.2.2.1 Overview
7.4.2.2.2 Analysis Consumables: Biobanks Market Revenue and Forecast to 2028 (US$ Million)
7.4.2.3 Processing Consumables
7.4.2.3.1 Overview
7.4.2.3.2 Processing Consumables: Biobanks Market Revenue and Forecast to 2028 (US$ Million)
7.4.2.4 Collection Consumables
7.4.2.4.1 Overview
7.4.2.4.2 Collection Consumables: Biobanks Market Revenue and Forecast to 2028 (US$ Million)
7.5 Services
7.5.1 Overview
7.5.2 Services: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)
7.5.2.1 Storage Services
7.5.2.1.1 Overview
7.5.2.1.2 Storage Services: Biobanks Market Revenue and Forecast to 2028 (US$ Million)
7.5.2.2 Processing Services
7.5.2.2.1 Overview
7.5.2.2.2 Processing Services: Biobanks Market Revenue and Forecast to 2028 (US$ Million)
7.5.2.3 Transport Services
7.5.2.3.1 Overview
7.5.2.3.2 Transport Services: Biobanks Market Revenue and Forecast to 2028 (US$ Million)
7.5.2.4 Supply Services
7.5.2.4.1 Overview
7.5.2.4.2 Supply Services: Biobanks Market Revenue and Forecast to 2028 (US$ Million)
7.6 Software
7.6.1 Overview
7.6.2 Software: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)
8. Asia Pacific Biobanks Market – By Sample
8.1 Overview
8.2 Asia Pacific Biobanks Market Share by Application - 2021 & 2028 (%)
8.3 Blood Products
8.3.1 Overview
8.3.2 Blood Products: Biobanks Market Revenue and Forecast to 2028 (US$ Million)
8.4 Human Tissues
8.4.1 Overview
8.4.2 Human Tissues: Biobanks Market Revenue and Forecast to 2028 (US$ Million)
8.5 Cell Lines
8.5.1 Overview
8.5.2 Cell Lines: Biobanks Market Revenue and Forecast to 2028 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Biobanks Market Revenue and Forecast to 2028 (US$ Million)
9. Asia Pacific Biobanks Market – By Application
9.1 Overview
9.2 Asia Pacific Biobanks Market Share by Application - 2021 & 2028 (%)
9.3 Regenerative Medicine
9.3.1 Overview
9.3.2 Regenerative Medicine: Biobanks Market Revenue and Forecast to 2028 (US$ Million)
9.4 Life Science Research
9.4.1 Overview
9.4.2 Life Science Research: Biobanks Market Revenue and Forecast to 2028 (US$ Million)
9.5 Clinical Research
9.5.1 Overview
9.5.2 Clinical Research: Biobanks Market Revenue and Forecast to 2028 (US$ Million)
10. Asia Pacific Biobanks Market – Country Analysis
10.1 Overview
10.1.1 Asia Pacific: Biobanks Market, by Country, 2021 & 2028 (%)
10.1.1.1 China: Biobanks Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.1.1 Overview
10.1.1.1.2 China: Biobanks Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.1.3 China: Biobanks Market, by Product and Service, 2019–2028 (USD Million)
10.1.1.1.3.1 China: Biobanks Market, by Equipment, 2019–2028 (USD Million)
10.1.1.1.3.2 China: Biobanks Market, by Consumables, 2019–2028 (USD Million)
10.1.1.1.3.3 China: Biobanks Market, by Services, 2019–2028 (USD Million)
10.1.1.1.4 China: Biobanks Market, by Sample, 2019–2028 (USD Million)
10.1.1.1.5 China: Biobanks Market, by Application, 2019–2028 (USD Million)
10.1.1.2 Japan: Biobanks Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.2.1 Overview
10.1.1.2.2 Japan: Biobanks Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.2.3 Japan: Biobanks Market, by Product and Service, 2019–2028 (USD Million)
10.1.1.2.3.1 Japan: Biobanks Market, by Equipment, 2019–2028 (USD Million)
10.1.1.2.3.2 Japan: Biobanks Market, by Consumables, 2019–2028 (USD Million)
10.1.1.2.3.3 Japan: Biobanks Market, by Services, 2019–2028 (USD Million)
10.1.1.2.4 Japan: Biobanks Market, by Sample, 2019–2028 (USD Million)
10.1.1.2.5 Japan: Biobanks Market, by Application, 2019–2028 (USD Million)
10.1.1.3 India: Biobanks Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.3.1 Overview
10.1.1.3.2 India: Biobanks Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.3.3 India: Biobanks Market, by Product and Service, 2019–2028 (USD Million)
10.1.1.3.3.1 India: Biobanks Market, by Equipment, 2019–2028 (USD Million)
10.1.1.3.3.2 India: Biobanks Market, by Consumables, 2019–2028 (USD Million)
10.1.1.3.3.3 India: Biobanks Market, by Services, 2019–2028 (USD Million)
10.1.1.3.4 India: Biobanks Market, by Sample, 2019–2028 (USD Million)
10.1.1.3.5 India: Biobanks Market, by Application, 2019–2028 (USD Million)
10.1.1.4 South Korea: Biobanks Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.4.1 Overview
10.1.1.4.2 South Korea: Biobanks Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.4.3 South Korea: Biobanks Market, by Product and Service, 2019–2028 (USD Million)
10.1.1.4.3.1 South Korea: Biobanks Market, by Equipment, 2019–2028 (USD Million)
10.1.1.4.3.2 South Korea: Biobanks Market, by Consumables, 2019–2028 (USD Million)
10.1.1.4.3.3 South Korea: Biobanks Market, by Services, 2019–2028 (USD Million)
10.1.1.4.4 South Korea: Biobanks Market, by Sample, 2019–2028 (USD Million)
10.1.1.4.5 South Korea: Biobanks Market, by Application, 2019–2028 (USD Million)
10.1.1.5 Australia: Biobanks Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.5.1 Overview
10.1.1.5.2 Australia: Biobanks Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.5.3 Australia: Biobanks Market, by Product and Service, 2019–2028 (USD Million)
10.1.1.5.3.1 Australia: Biobanks Market, by Equipment, 2019–2028 (USD Million)
10.1.1.5.3.2 Australia: Biobanks Market, by Consumables, 2019–2028 (USD Million)
10.1.1.5.3.3 Australia: Biobanks Market, by Services, 2019–2028 (USD Million)
10.1.1.5.4 Australia: Biobanks Market, by Sample, 2019–2028 (USD Million)
10.1.1.5.5 Australia: Biobanks Market, by Application, 2019–2028 (USD Million)
10.1.1.6 Rest of Asia Pacific: Biobanks Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.6.1 Overview
10.1.1.6.2 Rest of Asia Pacific: Biobanks Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.6.3 Rest of Asia Pacific: Biobanks Market, by Product and Service, 2019–2028 (USD Million)
10.1.1.6.3.1 Rest of Asia Pacific: Biobanks Market, by Equipment, 2019–2028 (USD Million)
10.1.1.6.3.2 Rest of Asia Pacific: Biobanks Market, by Consumables, 2019–2028 (USD Million)
10.1.1.6.3.3 Rest of Asia Pacific: Biobanks Market, by Services, 2019–2028 (USD Million)
10.1.1.6.4 Rest of Asia Pacific: Biobanks Market, by Sample, 2019–2028 (USD Million)
10.1.1.6.5 Rest of Asia Pacific: Biobanks Market, by Application, 2019–2028 (USD Million)
11. Impact Of COVID-19 Pandemic on Asia Pacific Biobanks Market
11.1 Asia Pacific: Impact Assessment of COVID-19 Pandemic
12. Asia Pacific Biobanks Market–Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 THERMO FISHER SCIENTIFIC INC.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Tecan Trading AG
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 QIAGEN
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Hamilton Company
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Avantor, Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 MICRONICS JAPAN CO., LTD.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 BD
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Taylor-Wharton
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Brooks Automation, Inc.
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Promega Corporation
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 SciSafe Inc.
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments
14. Appendix
14.1 About the Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. China: Biobanks Market, by Product and Service – Revenue and Forecast to 2028 (USD Million)
Table 2. China Biobanks Market, by Equipment – Revenue and Forecast to 2028 (USD Million)
Table 3. China Biobanks Market, by Consumables – Revenue and Forecast to 2028 (USD Million)
Table 4. China Biobanks Market, by Services – Revenue and Forecast to 2028 (USD Million)
Table 5. China: Biobanks Market, by Sample – Revenue and Forecast to 2028 (USD Million)
Table 6. China: Biobanks Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 7. Japan: Biobanks Market, by Product and Service – Revenue and Forecast to 2028 (USD Million)
Table 8. Japan Biobanks Market, by Equipment – Revenue and Forecast to 2028 (USD Million)
Table 9. Japan Biobanks Market, by Consumables – Revenue and Forecast to 2028 (USD Million)
Table 10. Japan Biobanks Market, by Services – Revenue and Forecast to 2028 (USD Million)
Table 11. Japan: Biobanks Market, by Sample – Revenue and Forecast to 2028 (USD Million)
Table 12. Japan: Biobanks Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 13. India: Biobanks Market, by Product and Service – Revenue and Forecast to 2028 (USD Million)
Table 14. India Biobanks Market, by Equipment – Revenue and Forecast to 2028 (USD Million)
Table 15. India Biobanks Market, by Consumables – Revenue and Forecast to 2028 (USD Million)
Table 16. India Biobanks Market, by Services – Revenue and Forecast to 2028 (USD Million)
Table 17. India: Biobanks Market, by Sample – Revenue and Forecast to 2028 (USD Million)
Table 18. India: Biobanks Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 19. South Korea: Biobanks Market, by Product and Service – Revenue and Forecast to 2028 (USD Million)
Table 20. South Korea Biobanks Market, by Equipment – Revenue and Forecast to 2028 (USD Million)
Table 21. South Korea Biobanks Market, by Consumables – Revenue and Forecast to 2028 (USD Million)
Table 22. South Korea Biobanks Market, by Services – Revenue and Forecast to 2028 (USD Million)
Table 23. South Korea: Biobanks Market, by Sample – Revenue and Forecast to 2028 (USD Million)
Table 24. South Korea: Biobanks Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 25. Australia: Biobanks Market, by Product and Service – Revenue and Forecast to 2028 (USD Million)
Table 26. Australia Biobanks Market, by Equipment – Revenue and Forecast to 2028 (USD Million)
Table 27. Australia Biobanks Market, by Consumables – Revenue and Forecast to 2028 (USD Million)
Table 28. Australia Biobanks Market, by Services – Revenue and Forecast to 2028 (USD Million)
Table 29. Australia: Biobanks Market, by Sample – Revenue and Forecast to 2028 (USD Million)
Table 30. Australia: Biobanks Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 31. Rest of Asia Pacific: Biobanks Market, by Product and Service – Revenue and Forecast to 2028 (USD Million)
Table 32. Rest of Asia Pacific Biobanks Market, by Equipment – Revenue and Forecast to 2028 (USD Million)
Table 33. Rest of Asia Pacific Biobanks Market, by Consumables – Revenue and Forecast to 2028 (USD Million)
Table 34. Rest of Asia Pacific Biobanks Market, by Services – Revenue and Forecast to 2028 (USD Million)
Table 35. Rest of Asia Pacific: Biobanks Market, by Sample – Revenue and Forecast to 2028 (USD Million)
Table 36. Rest of Asia Pacific: Biobanks Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 37. Organic Developments Done By Companies
Table 38. Inorganic Developments Done by Companies
Table 39. Glossary of Terms
LIST OF FIGURES
Figure 1. Asia Pacific Biobanks Market Segmentation
Figure 2. Asia Pacific Biobanks Market, By Country
Figure 3. Asia Pacific Biobanks Market Overview
Figure 4. Equipment Segment Held Largest Share of Product and Service Segment in Asia Pacific Biobanks Market
Figure 5. China is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Asia Pacific Biobanks Market, Industry Landscape
Figure 7. Asia Pacific: PEST Analysis
Figure 8. Experts Opinion
Figure 9. Asia Pacific Biobanks Market Revenue and Forecast to 2028 (USD Million)
Figure 10. Asia Pacific Biobanks Market, by Product and Service, 2021 & 2028 (%)
Figure 11. Equipment: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)
Figure 12. Storage Equipment: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)
Figure 13. Sample Analysis Equipment: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)
Figure 14. Sample Processing Equipment: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)
Figure 15. Sample Transport Equipment: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)
Figure 16. Consumables: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)
Figure 17. Storage Consumables: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)
Figure 18. Analysis Consumables: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)
Figure 19. Processing Consumables: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)
Figure 20. Collection Consumables: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)
Figure 21. Services: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)
Figure 22. Storage Services: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)
Figure 23. Processing Services: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)
Figure 24. Transport Services: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)
Figure 25. Supply Services: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)
Figure 26. Software: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)
Figure 27. Asia Pacific Biobanks Market Share by Application - 2021 & 2028 (%)
Figure 28. Blood Products: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)
Figure 29. Human Tissues: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)
Figure 30. Cell Lines: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)
Figure 31. Others: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)
Figure 32. Asia Pacific Biobanks Market Share by Application - 2021 & 2028 (%)
Figure 33. Regenerative Medicine: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)
Figure 34. Life Science Research: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)
Figure 35. Clinical Research: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)
Figure 36. Asia Pacific: Biobanks Market, by Key Country – Revenue (2021) (USD Million)
Figure 37. Asia Pacific: Biobanks Market, by Country, 2021 & 2028 (%)
Figure 38. China: Biobanks Market – Revenue and Forecast to 2028 (USD Million)
Figure 39. Japan: Biobanks Market – Revenue and Forecast to 2028 (USD Million)
Figure 40. India: Biobanks Market – Revenue and Forecast to 2028 (USD Million)
Figure 41. South Korea: Biobanks Market – Revenue and Forecast to 2028 (USD Million)
Figure 42. Australia: Biobanks Market – Revenue and Forecast to 2028 (USD Million)
Figure 43. Rest of Asia Pacific: Biobanks Market – Revenue and Forecast to 2028 (USD Million)
Figure 44. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
- THERMO FISHER SCIENTIFIC INC.
- Tecan Trading AG
- QIAGEN
- Hamilton Company
- Avantor, Inc.
- MICRONICS JAPAN CO., LTD.
- BD
- Taylor-Wharton
- Brooks Automation, Inc.
- Promega Corporation
- SciSafe Inc.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific biobanks market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific biobanks market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the biobanks market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution